1. Home
  2. UPLD vs QTTB Comparison

UPLD vs QTTB Comparison

Compare UPLD & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

N/A

Current Price

$0.55

Market Cap

28.4M

Sector

Technology

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$7.34

Market Cap

44.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UPLD
QTTB
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.4M
44.3M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
UPLD
QTTB
Price
$0.55
$7.34
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$3.75
$14.00
AVG Volume (30 Days)
266.9K
171.1K
Earning Date
06-03-2026
06-22-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
136.78
EPS
N/A
2.42
Revenue
$74,767,000.00
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.86
Revenue Growth
6.95
N/A
52 Week Low
$0.51
$1.38
52 Week High
$3.90
$7.10

Technical Indicators

Market Signals
Indicator
UPLD
QTTB
Relative Strength Index (RSI) 13.20 81.68
Support Level N/A $1.64
Resistance Level $1.62 N/A
Average True Range (ATR) 0.07 0.53
MACD -0.02 0.25
Stochastic Oscillator 8.53 91.95

Price Performance

Historical Comparison
UPLD
QTTB

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: